INMUNE BIO INC. Other Cash Equivalents, at Carrying Value
INMUNE BIO INC. (INMB) had Other Cash Equivalents, at Carrying Value of $47.83 million as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Notes › Cash and Cash Equivalents › Cash Equivalents, at Carrying Value
us-gaap:OtherCashEquivalentsAtCarryingValue · last filed 2023-08-07
- 2023-06-30: Other Cash Equivalents, at Carrying Value $47.83M.
- 2023-03-31: Other Cash Equivalents, at Carrying Value $51.00M.
- 2022-12-31: Other Cash Equivalents, at Carrying Value $52.15M.
- 2022-09-30: Other Cash Equivalents, at Carrying Value $57.41M.
| Period end | Other Cash Equivalents, at Carrying Value |
|---|---|
| 2023-06-30 | $47.83M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $51.00M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $52.15M 10-K · filed 2023-03-02 |
| 2022-09-30 | $57.41M 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |